A therapeutic vaccine is to used when a person already has been infected by a virus or bacteria.

The nasal vaccine which Eurocine is developing together with Bionor Immuno, has already been tested as a parenteral formulation in humans having AIDS.
The work includes the development of a nasal formulation using the Eurocine technologies, with subsequent clinical phase I/II testing on AIDS patients.

If you are an immunologist: the antigen consists of p24 peptides from gag.
Download the scientific report here >>